We have characterized and mapped variable and conserved neutralization epitopes of serogroup A strains of aquatic birnaviruses. Epitope mapping using monoclonal antibodies (MAbs) and Escherichia coli-expressed deletion fragments of VP2 of the N 1 strain of infectious pancreatic necrosis virus (IPNV) demonstrated that two variable epitopes, H8 and B9, depend on the variable region between amino acid 204-330. A conserved neutralization epitope, F2, was shown to depend on the same region as epitopes H8 and B9 but was additionally dependent on amino acids between 153-203. The neutralization epitopes H8, B9 and F2 were also shown to overlap by a competitive binding assay. One conserved neutralization epitope, AS-l, was not exposed on any of the recombinant VP2 deletion fragments and was therefore not possible to map. However, the MAbs AS-1 and F2 were partly competitive indicating that these epitopes are overlapping. All neutralization epitopes were independent of a conserved non-neutralization epitope, E4. Our results demonstrate that the central third of VP2 contains several partly overlapping neutralization epitopes, both variable and conserved among serogroup A strains of IPNV.
Introduction
Infectious pancreatic necrosis viruses (IPNV) are aquatic birnaviruses responsible for infectious pancreatic necrosis (IPN) in various fish species. Since 1986, acute IPN with considerable losses has frequently been diagnosed among farmed Atlantic salmon (Salmo salar) in Norway . Mortality in salmonids is believed to be highest in fry at first feeding and to become negligible by approximately 6 months of age (Frantsi & Savan, 1971) . However, recently an increasing number of IPN outbreaks with high mortalities have been reported among post-smolt of Atlantic salmon following transfer to seawater (Smail et al., 1992; . Developing an effective IPN vaccine is a major priority.
The birnavirus genus, family Birnaviridae, contains animal viruses with double-stranded bisegmented (segments A and B) RNA genomes contained within a non-* Author for correspondence. Fax +47 55 96 01 35. t Present address: Laboratory of Microbial Genetechnology, Agriculture University of Norway, N1432 As, Norway. enveloped icosahedral capsid. Segment A encodes three known gene products within one large open reading frame (Duncan & Dobos, 1986; Hfivarstein et al., 1990) , and segment B encodes a RNA-dependent RNA polymerase (VPI) (Duncan et al., 1991) . The segment Aencoded polyprotein, pVP2-NS-VP3, is autocatalytically cleaved by the endoprotease (NS) to produce the structural proteins VP2 and VP3 (Duncan et al., 1987) . Variations in the polypeptide patterns of different virus strains have been reported (Macdonald et al., 1982; Christie et al., 1988) .
The classification of aquatic birnaviruses is disputed and varies depending on the method used (Caswell-Reno et al., 1986 , 1989 Christie et al., 1988; Heppell et al., 1993) . Based on serological analyses, the aquatic birnaviruses have been divided into two serogroups (A and B) (Hill & Way, 1988) . The predominant serogroup A is found globally and includes most serotypes known to be pathogenic to fish.
The major neutralization epitopes of aquatic birnaviruses are localized within VP2 (Caswell-Reno et al., 1986; Christie et al., 1990; Tarrab et al., 1993) , but neutralization epitopes have also been suggested for VP3 ).
An internal variable region located in the central part 0001-2953 © 1995 SGM of VP2 has been identified (H~tvarstein et al., 1990) and was suggested to contain serotype-specific epitopes of birnaviruses. A VP2-specific monoclonal antibody (MAb), AS-l, neutralizing all serogroup A strains of IPNV has been reported (Caswell-Reno et al., 1989; Lipipun et al., 1991) , indicating the presence of a conserved neutralization epitope on VP2. Due to the antigenic variability of aquatic birnaviruses a subunit vaccine against IPN should be based on neutralization epitopes known to be conserved among the relevant virus strains.
In order to develop an effective subunit vaccine the epitopes responsible for protective immunity have to be identified. In this communication we report the characterization and mapping of variable and conserved neutralization epitopes on serogroup A strains of aquatic birnaviruses using MAbs and Escherichia coli-expressed deletion fragments of VP2.
Methods
Cells and viruses. The VR-299 (A1) and West Buxton (A1) virus strains were obtained from Dr J. C. Leong (Oregon State University, USA), the Sp (A2) and Ab (A3) virus strains were obtained from Dr P. E. V. Jergensen (The State Veterinary Serum Laboratory, Arhus, Denmark), the Hecht (A4) virus strain from Dr W. Ahne (University of Munich, Germany), the Tellina (A5) virus strain from Dr D. A. Smail (Agriculture and Fisheries Department Marine Laboratory, Aberdeen, Scotland), the Canada-l, -2 and -3 (A6, A7 and A8) virus strains from Dr B. L. Nicholson (University of Maine, USA) and the Jasper-Dobos virus strain (A9) from Dr P. Dobos (University of Guelph, Canada). Isolation of the N1 virus strain (A10) from Norwegian Atlantic salmon (Salmo salar) has been described elsewhere (Christie et al., 1988) . All viruses were propagated in Chinook salmon embryo (CHSE-214) cells grown by standard methods. During virus propagation no serum was added to the cell growth medium. Virus used in sandwich ELISA or neutralization assay was either taken directly from the master seed or propagated once in CHSE-214 cells. Virus for SDS-PAGE and Western blotting was purified according to Christie et al. (1988) .
Monoclonal antibodies. The VP2-specific MAbs F2 and E4 were produced against the N1 (A10) strain of IPNV as described elsewhere for the VP2-specific MAbs H8, B9 and for the VP3-specific MAb C12 . MAb AS-1 (Caswell-Reno et al., 1989) , was kindly provided by Dr B. L. Nicholson (University of Maine, USA). MAbs H8, B9 and F2 were purified by the MAbTrap G procedure (Pharmacia) and labelled with biotin by standard methods using 100 !ag N-hydroxysuccinimide biotin/mg immunoglobulin.
Isolation and subcloning of cDNA encoding VP2. A cDNA encoding VP2 was isolated from the ]ambda gtl0 cDNA library previously used for sequencing segment A of the N1 virus strain (H~varstein et al. 1990) . A VP2 cDNA of approximately 1.4 kbp was subcloned into the Fig. 1 . Restriction enzyme sites in pET11-VP2 used to construct the pET11-VP2-derived deletion mutants described in Table 1 .
EcoRI site of the pGEM-7Zf(+) vector (Promega) generating the plasmid pGEM-VP2. The coding potential of the subcloned VP2 cDNA (nucleotides 136-1487 of segment A) was determined by chain termination nucleotide sequencing of the 5' and Y ends as described by H~varstein et al. (1990) , using primers (Promega) complementary to the T7 and SP6 promoter regions in pGEM-7Zf( + ). A PCR fragment complementary to nt 739-1123 in segment A of the IPNV N1 strain was produced using the pGEM-VP2 as template. The upstream primer (26-mer) introduced a BamHI site, while the downstream primer (33-mer) introduced a TAA translation stop codon and a HindIII site. The PCR fragment was digested with BamHI and HindIII, ligated into similarly digested pRIT28 vector, generating pRIT28-dVP2, and sequenced by the direct solid-phase procedure (Hultman et al., 1988) .
Construction of expression plasmids encoding VP2 fragments. A
BamHI site was generated in pGEM-VP2 5' to the VP2 cDNA by digestion with XhoI, blunt-ended with Klenow fragment and insertion of the BamHI linker 5'-CGGATCCG-3' (Pharmacia), generating the plasmid pGEM-VP2 2xBamHI. The reading frame of the VP2 cDNA was determined by standard chain termination DNA sequencing using the T7 primer. Further DNA constructions for expression of VP2 fragments in the pET1 ld (Novagen) and the pVABBmp8 expression plasmids are described in Table 1 . Plasmid pYABBmp8 is constructed by insertion of a XbaI-EcoRI fragment, encoding the serum albumin binding domain (BB) from streptococcal protein G, from plasmid pTrpBB (Oberg et al., 1994) , into a similarly digested pRIT44 (K6hler et al., 1991) .
The restriction sites in pETll-VP2 used to construct the VP2 deletion fragments as described in Table 1 are illustrated in Fig. 1 (DE3) pLysS (Novagen) was used for expression of VP2 fragments subcloned in the pET1 ld expression vector. E. eoli containing pET1 ld constructions was grown at 30 °C in LB-medium containing ampicillin (Astra; 200 gg/ml) and chloramphenicol (20 gg/ml). Gene expression was induced when the cultures reached an ODss 0 of 0.6 to 1"0 by adding IPTG (1 raM; Sigma) and additional ampicillin (200 ~tg/ml). Following induction for 2 h, the cells were harvested by centrifugation (3000 g for 20 rain) and concentrated 10 times by resuspension in ice-cold 1 x TNE-T buffer (0.1 M-Tris-HC1 pH 8-0, 0.3 M-NaC1, 1 mM-EDTA, 0.1% Triton X-100) containing 1 mg/ml chicken egg-white lysozyme (Sigma). The cells were incubated on ice and constantly agitated for 2 h, at which point DNaseI (3 U/ml; Sigma) and MgC12 (1 mM) were added. Incubation and agitation continued overnight, after which the suspensions were heated to 70 °C for 15rain, cooled on ice and harvested by centrifugation (4300 g, 20 min). The pellets were washed for l0 min, twice in ice-cold 2 x TNE-T buffer and twice in ice-cold sterile distilled water prior to SDS-PAGE analysis and lyophilization. For gel filtration, lyophilized samples were solubilized in ice-cold 6 M guanidine.HC1, 16 mM-Tris-HC1 pH 7.4, to a final concentration of 10-20 mg/ml. Undissolved material was removed by 0.22 lain filtration or by centrifugation (12 000 g for 15 rain) and samples of 200 gl applied on a Superose 12 HR 10/30 gel filtration column (Pharmacia) using the liquid chromatography (FPLC) system (Pharmacia) according to the manufacturer's instructions. Eluted fractions were monitored at 280 nm and analysed by SDS PAGE. Relevant fractions were pooled and dialysed overnight against ice-cold 2 M-guanidine.HCl, 16 mM-Tris-HC1 pH 7-4. The protein concentrations were determined according to the A280, and all samples were diluted in additional 2 M-guanidine.HC1 to a final protein concentration of approximately 100 ~tg/ml. E. coli strain RRIAMI5 (Rtither, 1982) was used for expression of the pVABBmp8 constructions. E. coli cells harbouring the pVABBdVP2 or the pVABBmp8 vector were grown at 30 °C in tryptic soy broth medium (Difco; 30 mg/ml) with addition of yeast extract (Difco; 5mg/ml) and ampicillin (Astra; 100 btg/ml)_ Induction of gene expression with indole acrylic acid was perfbrmed as described by Krhler et al. (1991) at OD~50 of 1-5. Cells were harvested by centrifugation (3000 g for 20 min) at OD~ 0 of 6 and resuspended in icecold TN-Tween buffer (25 mM-Tris-HCl pH 7-4, 150 mM-NaC1, 0.05 % Tween-80). The intracellular proteins were released by pulsed sonication for 6 min and the BB-dVP2 and BB proteins purified on a HSA-Sepharose affinity chromatography column as described by Nygren et al. (1988) . Eluted fractions were collected according to A~s 0 and analysed by SDS PAGE. Relevant fractions were pooled, the protein concentration determined by A2s 0 analysis, lyophilized and resuspended in 2 M-guanidine.HC1 to a final protein concentration of approximately 100 gg/ml.
SDS-PAGE and Western blotting. SDS-PAGE was performed by
standard methods using 4% stacking gels and 12% resolving gels.
Purified virus (10 gg/cm gel) or E. coli containing recombinant VP2 fragments was solubilized by boiling for 2 rain in sample buffer (62.5 mM-Tris-HC1, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol and 0.001% bromophenol blue). Samples containing guanidine.HCl (6 M or 2 M) were diluted 10-fold in pre-heated (98 °C) sample buffer, boiled for 2 min and loaded onto a pre-heated polyacrylamide gel (100 V for 10 min at room temperature). The gels were stained by standard methods using Coomassie brilliant blue or silver nitrate, or soaked for 30 min in electroblotting buffer (0"25 M-Tris-HCI pH 8-3, 0'192 M-glycine, 20 % methanol) and electroblotted onto nitrocellulose (NC) sheets (0.45 gm; Schleicher & Schuell). Following post-coating of the NC sheets with 3 % (w/v) dry milk (Nestl6 non-fat instant milk) in TBS-Tween (25 mM-Tris-HC1, pH 7-4, 2-5 mM-KCI, 0.135 M-NaCI and 0.05 % Tween-20) for 60 rain at room temperature, the NC sheets were incubated overnight at 4 °C with hybridoma cell culture supernatant. For comparison of virus strains, biotin-labelled goat anti-mouse secondary antibodies (Amersham), diluted 1:200 were incubated at room temperature for 60 min before addition of peroxidase-conjugated streptavidin (Amersham) diluted 1:3000, and a further 30min incubation. The NC sheets were developed for 10 rain with peroxidase substrate (0.1% diaminobenzidine in 0.5 ~-Tris-HC1 pH 7-5 and 0" 1% H202), and the reaction stopped by washing with distilled water. For analysis of recombinant VP2 fragments alkaline phosphatase (AP) conjugated goat anti-mouse antibodies (Bio-Rad) diluted 1 : 2000 were incubated at room temperature for 60 min. Colour development was performed using the AP conjugate substrate kit (Bio-Rad) according to the supplier's instructions.
All antibody dilutions were made in TBS-Tween containing 1% (w/v) dry milk and all antibody incubations were followed by washing four times with TBS-Tween for 10 min at room temperature.
Sandwich ELISA and competitive binding assay. Sandwich ELISA experiments with MAb AS-1 were performed as described by Melby & 
The maximum dilutions giving 50 % reduction in plaque forming units were > 1 : 1000 ( + + +), between 1 : 100 and 1 : 1000 (+ + ) or < 1 : 100 (+).
~ The ELISA results except for MAb AS-1 are based on Melby & Christie (1994) . The relative recognition of virus was quantified to be more than eight times (+ + +), between four and eight times (+ +), between two and four times (+) or less than two times the control value.
{ The numbers in the parentheses correspond to the proposed serotyping of aquatic birnaviruses. ND, Not done. Christie (1994) using the N 1 strain of IPNV as antigen. For competitive binding analysis of the MAbs excess of an unlabelled MAb (hybridoma medium) was incubated overnight at 4 °C, followed by a 3 h incubation at room temperature with a sub-saturating concentration (approximately 3 lag/ml) of a purified biotin-labelled MAb, and a 30 min incubation with peroxidase-conjugated streptavidin (Amersham) diluted 1:3000. The positive controls were incubated with 100 pl PBSTween (10 mN-Na2HPO4, 1.75 mM-KH~PO 4, 150 mM-NaC1, 0.05% Tween-20) containing 1% dry milk instead of excess of unlabelled competitive MAb.
Neutralization plaque reduction assay. The dilution of the individual
MAbs giving 50 % plaque reduction after 1 h incubation with virus was determined. The concentration of infectious virus (p.f.u.) was estimated by a plaque assay using agarose with a gelling temperature less than 28°C (SeaPlaque; FMC-BioProducts). Virus suspension (100gl) diluted in Eagle's MEM (Flow) was placed centrally on a monolayer of CHSE-214 cells in a 26 x 33 mm tissue culture plate well (Nunc) and incubated at 20 °C with 0.5 % CO 2. After 1 h, 5 ml growth medium with reduced fetal bovine serum concentration (2 % v/v) containing 0.5 % (w/v) solubilized agarose and equilibrated to 22 °C, was added. Following a further 36 h incubation, the cells were stained with 2 ml 0.001% neutral red in 0.15 M-NaC1 for 2 h, and the plaques were counted.
Dot blot analysis with MAbs and deletion fragments of VP2.
Purified E. coli-expressed VP2 fragments 1 gl (approx. 100 ng) and BB control antigen were dotted onto NC strips, air dried for 30 min and washed with TBS for 10 min at room temperature. CHSE-214 culture medium (1 pl) with propagated N1 virus strain diluted 1:3 in 6 M-guanidine-HCI (denatured) or in 16 mM-Tris-HCl pH 7.4 (native), were dotted onto the NC as positive control antigens. Protein immobilization was demonstrated using Colloidal Gold Total Protein Stain (Bio-Rad) according to the supplier's instructions. Post-coating, incubation with hybridoma cell culture supernatant, AP conjugate incubation and colour development were performed as described for Western blotting.
Sequence analysis. Jameson-Wolf antigenicity index analysis was performed using GCG package software (Madison, WI, USA). (Melby & Christie, 1994) .
Results

Characterization of epitopes on aquatic birnavirus strains
The neutralizing MAb AS-1 reported to react with all tested serogroup A virus strains by dot blot (CaswellReno et al., 1989 ) recognized all tested virus strains except Hecht (A4) and Tellina (A5) by ELISA, and neutralized all virus strains except Hecht (A4). MAb F2 both neutralized and reacted by Western blotting with all virus strains except Tellina (A5), although it did give a weak reaction with this virus strain by ELISA. On the other hand, although MAb F2 neutralized Canada-2 and -3 (A7 and A8), these virus strains were not reactive by ELISA. MAbs H8 and B9 neutralized all virus strains recognized by ELISA. MAb H8 neutralized the virus strains West Buxton (A1), Sp (A2), Jasper-Dobos (A9) and N1 (A10), while MAb B9 only neutralized the Sp (A2) and the N1 (A10) virus strains. However, in Western blotting MAb H8 recognized all virus strains except Tellina (A5) and MAb B9 recognized all virus strains except Hecht (A4) and Tellina (A5). The nonneutralizing VP2-specific MAb E4, which recognized all tested serogroup A strains by ELISA, did not recognize the Sp (A2), Tellina (A5), Canada-2 (A7) and Canada-3 (A8) virus strains by Western blotting. Table 3 shows the results of competitive binding ELISA performed to determine whether the virus neutralizing MAbs were independent of each other and of the VP2-specific non-neutralizing MAb E4. Pre-incubation with MAb H8 showed a very limited effect on the binding of the labelled MAbs B9 (16%) and F2 (17%) to the N1 (A10) virus strain. However, MAb B9 partly blocked the binding of both MAb H8 (32%) and F2 (48 %), and MAb F2 blocked the binding of MAb B9 (62 %) very effectively relative to the blocking effect of MAb F2 on itself (76 %). Furthermore, pre-incubation with MAb F2 partly blocked the binding of H8 (38 %) to the virus. MAb AS-1 partly blocked the binding of MAb F2 (37 %), but had little effect on MAb B9 (10 %) and MAb H8 (13%). Pre-incubation with the non-neutralizing MAb E4 showed no competitive binding for any of the virus-neutralizing MAbs tested.
Competitive binding of virus neutralizing MAbs
Expression of VP2 fragments in Escherichia coli
The VP2-encoding cDNAs of the expression plasmid constructs described in Table 1 were successfully overexpressed in E. coli. With exception of the deletion fragment VP2ApAatII, which showed the lowest level of expression in E. coli, protein purification resulted in approximately 70-95 % pure deletion fragments of VP2, determined by SDS-PAGE and silver staining (data not shown).
Mapping of MAb specificity by reaction with deletion fragments of VP2
The recognition of recombinant deletion fragments of VP2 by MAbs was analysed by Western blotting and dot blot analysis. There were no differences in the qualitative reaction pattern of the individual virus-neutralizing MAbs with the VP2 fragments in the Western blotting (data not shown) compared to the dot blot analysis (Fig.  2) . Following deletion of amino acids (aa) 153-234 at the N-terminal part (antigen VP2AHincI1) or aa 270-453 at the C-terminal part (antigen VP2ApAatlI) of VP2, the virus-neutralizing MAbs H8, B9 and F2 were all unable to bind these deletion fragments. Internal deletion of aa 201-270 (antigen VP2ApHinclIASaclIApAatlI) also abolished the binding of the virus neutralizing MAbs H8, B9 and F2. The smallest VP2 fragment recognized by the MAbs H8 and B9 was antigen , and the smallest VP2 fragment recognized by the MAb F2 was antigen VP2ApHinclIAAvalI (aa 153-330) . The weaker binding of MAb F2 in the dot blot analysis compared to MAbs H8 and B9 could not be detected by Western blotting (data not shown). The binding of the MAbs F2 and E4 to denatured virus was very weak compared to binding to native virus (Fig. 2) . MAb E4 was unable to bind any recombinant VP2 fragments in the dot blot analysis but recognized antigen VP2 (aa 3453) in Western blotting (data not shown). The conserved virusneutralizing MAb AS-1 was only able to bind to native virus in the dot blot analysis. No binding of any MAb to the control antigen (BB) or binding of the VP3-specific control MAb C12 to any VP2 deletion fragments were detected.
Amino acid sequence analysis
Eleven regions with a theoretical Jameson-Wolf antigenicity index of 1.5 or more were identified within the VP2 amino acid sequence (aa 1-500) of the N1 virus (1990) . strain (Fig. 3) . All 11 regions were located between aa 149 and 390.
Discussion
Our results demonstrate that the central third of VP2 of the serogroup A strains of IPNV contains at least three partly overlapping neutralization epitopes, two variable and one conserved. The variable epitopes B9 and H8 depend on amino acids between 204 and 330 which correspond to almost the entire variable region of VP2 identified by Hfivarstein et al. (1990) (Fig. 3) . The conserved neutralization epitope F2 depends not only on the region between amino acid 204 and 330 but also on some amino acids between 153 and 203. Deletion of amino acids 153 to 234 or 270 to 330 hindered binding of the MAbs H8, B9 and F2 to the deletion fragments of VP2 (Fig. 2) , demonstrating the conformation-dependent nature of these epitopes. However, since all these MAbs recognized denatured VP2, the epitopes must easily renature to a form recognizable by the MAbs. The conserved and conformation-dependent epitopes AS-1 and E4 were not possible to map since no binding to VP2 deletion fragments could be detected. However, MAb AS-1 showed some competitive binding with the F2 MAb indicating that the F2 and the AS-1 epitope or parts of them merge into each other. The competitive binding assay further indicated that the neutralization epitopes H8, B9 and F2 are overlapping and that they are independent of the conserved non-neutralization epitope E4.
The results of the Jameson-Wolf antigenicity index sequence analysis also indicate that the central third of VP2 contains the dominant epitopes of VP2. Of the 11 regions within VP2 with a theoretical Jameson-Wolf antigenicity index of 1'5 or more, seven were located within the F2 epitope region which consists of approximately 35 % of the VP2 sequence.
As far as we know regions of VP2 outside the variable region have not yet been shown to be part of any neutralization epitopes of birnaviruses. For infectious bursal disease virus (IBDV), a birnavirus pathogenic to chickens, only variable epitopes have been mapped (Azad et al., 1987; Schnitzler et al., 1993) . Conserved epitopes of IBDV, like the AS-1 epitope of IPNV, appear to be highly conformation-dependent (Snyder et al., 1988 (Snyder et al., , 1992 and therefore difficult to map. Recently Vakharia et al. (1994) reported major amino acid variation within the variable region of VP2 between neutralizing MAb escape strains of IBDV. In spite of major sequence variation within the variable region of these virus strains, one conserved neutralization epitope was demonstrated for all virus strains, indicating that regions outside the variable region may be part of this epitope.
Previously we reported that the IPNV-neutralizing MAbs H8 and B9 were unable to recognize the Sp (A2) virus strain . Later other clones of the same passage of the Sp (A2) type strain have shown positive results with MAb H8 and variable results with MAb B9 (Melby & Christie, 1994) . This further demonstrates the high variability of epitopes H8 and B9. Although the Sp (A2) and the N1 (A10) virus strains are serologically related, the results from the characterization of epitopes on aquatic birnavirus strains presented in Table 2 demonstrate that they are not identical. Of the European virus strains only the two related virus strains Sp (A2) and N1 (A10) contain the variable H8 epitope. It was therefore surprising that the H8 epitope is present on the Canadian Jasper-Dobos (A9) and the American West Buxton (A1) virus strains. The amino acid sequences of the N1 (A10) and the Jasper-Dobos (A9) virus strains show a high degree of variation within the H8 epitope region (Hgtvarstein et al., 1990) while the Jasper-Dobos (A9) and the West Buxton (A1) are believed to belong to the same genogroup . Furthermore, both MAb H8 and B9 recognized a greater number of virus strains by Western blotting when compared with ELISA and neutralization assays. This indicates that denaturation induces exposure of internal epitopes or change in conformation. Consequently, although located within a highly variable region, the heterogeneity of some epitopes of aquatic birnaviruses appears to depend on conformational variation, which can be induced by minor changes in the amino acid sequence. Major changes in the amino acid sequence are usually a consequence of evolution and would therefore not be as effective a mechanism for viruses to escape neutralizing antibodies (antigenic drift) as conformation variation following minor changes in the amino acid sequence. Recently, Pryde et at. (1993) identified only two amino acid variations within the variable region of a Scottish Sp (A2) virus strain compared to the N1 (A10) virus strain, both located at the periphery of the H8-B9 epitope region. For IBDV, sequence analysis of neutralization escape variants of IBDV has proven that minor amino acid variations may induce neutralization escape variants (Lana et al., 1992; Vakharia et al., 1994) .
Virus-neutralizing MAbs that bind VP2 of aquatic birnaviruses by Western blotting have also been reported by others and the epitopes suggested to be of linear nature . However, epitopes which are recognized by MAb following denaturation by, for instance, SDS-PAGE and Western blotting are not necessarily linear. In fact, specific procedures to increase binding of MAbs to conformation-dependent epitopes following Western blotting have been developed (Dunn, 1986) . The neutralization epitope defined by MAb AS-1 and common to all serogroup A virus strains except Hecht (A4) appears unable to spontaneously renature, indicating that the conformation of epitope AS-1 on the virus capsid is of a more complex nature than that of epitopes H8, B9 and F2.
With regard to a candidate subunit vaccine against IPN in fish, the F2 epitope should be an important component since it is common to all serogroup A strains of IPNV. The Tellina strain (A5), which is not neutralized by MAb F2, is an aquatic birnavirus isolated from molluscs and is not known to cause IPN in fish. Furthermore, a structure resembling the epitope F2 is present on recombinant VP2.
